Artem Oganesyan, Internal Medicine Resident Physician at Jefferson Abington Hospital, shared a post on LinkedIn:
“Presenting at ASH25 in Orlando, FL
Deep dive through meta-analysis of clinical trials into Nivolumab & Pembrolizumab efficacy in r/r Hodgkin lymphoma subgroups, call to move for more personalized approach.
Thank you, American Society of Hematology for Abstract Achievement Award
Thankful to co-authors for their contributions.”
Read More updates form ASH25 on OncoDaily.
